The results of the study showed that only one patient had a serious adverse event (that was not related to the drug), that gold nanoparticles were found in the tumor tissue and inside the tumor cells, and that there is a correlation between the accumulation of the particles and the inhibition of Bcl2L12 protein (21). The gene discussed is BCL2L12; the disease is neoplasm.